GLAXOSMITHKLINE has announced the establishment of a new San Francisco facility to work on CRISPR gene-editing technology.
The new Laboratory for Genomic Research, funded to the tune of US$67 million over five years, will house 24 full-time University of California researchers along with up to 14 GSK employees, with a focus on immunology, oncology and neurology.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Jun 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Jun 19
